𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Precipitable immune complexes in Hodgkin's disease

✍ Scribed by Hans-Hartwig Euler; Rosemarie Béress; Imme Moldenhauer; Helmut Löffler


Publisher
John Wiley and Sons
Year
1983
Tongue
French
Weight
464 KB
Volume
32
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Sera from 28 untreated patients with Hodgkin's disease and from 120 healthy controls were investigated for the presence of circulating immune complexes using a modified 3% polyethylene glycol precipitation method with subsequent quantification of the precipitated protein. Elevated levels of precipitable protein were found in 79% (p <0. 005) of Hodgkin's disease sera. The degree of elevation was associated with disease activity including the presence of B‐symptoms. Constant and pronounced increase of precipitable protein was found in six patients with stage‐III B nodular sclerosis subtype, thus exceeding the average amount of precipitable protein in healthy controls by a factor of 3–4. The erythrocyte sedimentation rate in 20 patients correlated with the amount of precipitable protein (r = 0. 79). Additionally, partial component analysis of the precipitates was carried out by laser nephelometry. Immunoglobulins and complement components were identified as being major components of the precipitated material in sera both from patients and healthy controls, thus confirming the probability of the immune complex nature of the precipitates. Significant differences between patients and healthy controls concerned the amount of precipitable components. Elevation of precipitable IgM was found to be the most sensitive parameter (86% above X̄ + 2 sd of normal controls, p <0. 005). Increased amounts of precipitable IgG, C4, and Clq were found in 57‐46% of patients' sera. Elevation of precipitable IgA and C3c were identified less often. The results suggest the quantification of precipitable immune complexes and their components to be of value as adjuncts in determining disease activity in Hodgkin's dis‐ease.


📜 SIMILAR VOLUMES


Cellular immunity in Hodgkin's disease
✍ S. H. Advani; H. D'silva; B. P. Gothoskar; K. A. Dinshaw; C. N. Nair; R. Gopalkr 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB
Immune thrombocytopenic purpura in Hodgk
✍ Kamran Hassidim; Robert McMillan; Michael S. Conjalka; John Morrison 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

## Abstract Immune thrombocytopenic purpura is rarely seen in Hodgkin disease and the presence of platelet‐associated antibody has not been previously reported in these patients. A patient with Hodgkin disease is described who developed a destructive thrombocytopenia demonstrated by shortened plate

Hodgkin's disease after non-Hodgkin's ma
✍ Eric Senaldi; Moon H. Lee; Ilona Toth; William Grace 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

Hodgkin's disease (HD) after treatment of non-Hodgkin's lymphoma (NHL) has been reported but is extremely rare, and to the authors' knowledge has not been reported in patients with acquired immune deficiency syndrome (AIDS). The authors present a case of an AIDS patient who developed mixed cellulari

Immune dysfunction in non-Hodgkin's lymp
✍ Dr. S. H. Advani; K. A. Dinshaw; C. N. Nair; R. Gopal; G. V. Talwalkar; Y. S. Iy 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB
Hodgkin's disease in Kenya
✍ Malkit S. Riyat 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views